Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAMper Trial of progesterone after mifepristone
ACTRN12620000596909Phase 2Recruiting
- Sponsor
- University of New England
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of progesterone in pregnancy, sponsored by University of New England. Primary endpoint: Viable pregnancy by ultrasound. Started Oct 2020; status: recruiting.
02
Drugs
progesterone
03
Conditions
pregnancy
Beyond the preview
Go deeper on ACTRN12620000596909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000596909.